Page last updated: 2024-10-26

dipyridamole and Intestinal Diseases

dipyridamole has been researched along with Intestinal Diseases in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cottafava, F1
Brida Di PriĆ², S1
Buono, S1
Nardelli, E1
Della Casa, C1
Boeri, L1
Dodero, P1
Cleophas, TJ1
Tavenier, P1
Niemeyer, MG1

Other Studies

2 other studies available for dipyridamole and Intestinal Diseases

ArticleYear
[Thrombocytosis. Considerations on a case with intestinal thrombosis diagnosed at the age of 4 months and treated with platelet anti-aggregants].
    Minerva pediatrica, 1981, Volume: 33, Issue:24

    Topics: Aspirin; Dipyridamole; Female; Humans; Infant; Intestinal Diseases; Thrombocytosis; Thrombosis

1981
The risk of emergency intestinal bleeding among users of acenocoumarin: a population-based cohort study.
    Angiology, 1993, Volume: 44, Issue:2

    Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cas

1993